Skip to main content
Erschienen in: BMC Family Practice 1/2015

Open Access 01.12.2015 | Research article

Clinical and haematological predictors of antibiotic prescribing for acute cough in adults in Swiss practices – an observational study

verfasst von: Sven Streit, Peter Frey, Sarah Singer, Ueli Bollag, Damian N Meli

Erschienen in: BMC Primary Care | Ausgabe 1/2015

Abstract

Background

Acute cough is a common problem in general practice and is often caused by a self-limiting, viral infection. Nonetheless, antibiotics are often prescribed in this situation, which may lead to unnecessary side effects and, even worse, the development of antibiotic resistant microorganisms worldwide. This study assessed the role of point-of-care C-reactive protein (CRP) testing and other predictors of antibiotic prescription in patients who present with acute cough in general practice.

Methods

Patient characteristics, symptoms, signs, and laboratory and X-ray findings from 348 patients presenting to 39 general practitioners with acute cough, as well as the GPs themselves, were recorded by fourth-year medical students during their three-week clerkships in general practice. Patient and clinician characteristics of those prescribed and not-prescribed antibiotics were compared using a mixed-effects model.

Results

Of 315 patients included in the study, 22% were prescribed antibiotics. The two groups of patients, those prescribed antibiotics and those treated symptomatically, differed significantly in age, demand for antibiotics, days of cough, rhinitis, lung auscultation, haemoglobin level, white blood cell count, CRP level and the GP’s license to self-dispense antibiotics. After regression analysis, only the CRP level, the white blood cell count and the duration of the symptoms were statistically significant predictors of antibiotic prescription.

Conclusions

The antibiotic prescription rate of 22% in adult patients with acute cough in the Swiss primary care setting is low compared to other countries. GPs appear to use point-of-care CRP testing in addition to the duration of clinical symptoms to help them decide whether or not to prescribe antibiotics.
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

SS: Involved in statistical analysis and interpretation of the data, drafting the manuscript and given final approval to the version to be published. PF: Involved in conception and design of the study, acquisition of data, revising the manuscript and given final approval to the version to be published. SaS: Involved in conception and design of the study, revising the manuscript and given final approval to the version to be published. UB: Involved in conception and design of the study, drafting and revising the manuscript and given final approval to the version to be published. DM: Involved in conception and design of the study, drafting and revising the manuscript and given final approval to the version to be published.
Abkürzungen
CRP
C reactive protein
FBC
Full blood count
GP
General practitioner
WBC
White blood cells

Background

Acute cough is one of the main reasons why patients see their General Practitioner (GP) [1]. Cough combined with other signs of respiratory infection, such as fever, rhinitis, sore throat, or discoloured sputum, is frequently caused by a virus, in which case treatment with antibiotics is not necessary. Antibiotics do not shorten the illness and may be associated with side effects [2,3]. Furthermore, the worldwide overuse of antibiotics is one of the main reasons for the development of resistance [4,5].
The antibiotic prescription rate in patients with acute cough varies largely in different countries, from 15% [6] to 83% [4]. Variations in antibiotic prescribing also exist in general practices within a country [7]. Different factors are known to increase the likelihood of prescription of antibiotics, such as the patient’s expectation [8,9], old age [10], female gender [11], and longer duration of symptoms [12,13]. The following GP-related factors also influence the prescription rate: the assumption that patients want antibiotics [14,15], more or less years in practice [15-17], and the license to self-dispense antibiotics [18]. Patients’ assumption that antibiotics help and the GPs’ fear of a devastating outcome are two more reasons why antibiotics are over-prescribed in patients with acute cough [8,9].
In a study conducted in Switzerland [19], 27% of patients with acute respiratory tract infection were treated with antibiotics, less compared to other countries. As in countries such as Scandinavian ones, the primary care system in Switzerland uses point of care devices in practices for full blood count (FBC) and C-reactive protein (CRP) testing, but about a third of all GPs have access to chest radiography in their own practice. Many practitioners are licensed to dispense medications, including antibiotics. Although many GPs act as gatekeepers to the health care system, patients are free to attend a physician of their choice, including specialists in secondary care. Accordingly there are no registered patient lists.
The aim of the present study was to assess factors associated with the prescription of antibiotics in patients presenting with acute cough and to scrutinize the role of point-of-care FBC, CRP testing and the immediate access to chest X-rays.

Methods

Study population

We focused on a sample of consecutive adult patients seeing their GPs because of a cough lasting less than 3 weeks. We excluded patients with asthma, chronic obstructive pulmonary disease (COPD), gastro-oesophageal reflux disease, the use of ACE-inhibitor, immunodeficiency or pregnancy. Medical students were recruited to collect the data during their clinical clerkships within general practice. Practices were located in and around the city of Bern, Switzerland.

Processes and outcomes

Between September and November 2013, 39 medical students volunteered to record data on every adult patient attending a GP because of cough during their three-week GP attachments. Every student was only with one GP, forming a GP/student pair. Each pair of GP and student included a different number of patients (median 5, min. 1, max. 27). GPs were aware of the purpose of the study and the recording of data. After each consultation, the medical student and GP together assessed various baseline characteristics. These meetings allowed for the inclusion of data even if students occasionally were not present in every consultation, such as in the case of the students’ being occupied with other tasks, and also for teaching purposes, including the assessment of clinical signs, laboratory results and chest x-rays.

Ethical considerations

This study did not interfere with the consultation between patients and GPs. Data available from the consultation were recorded anonymously. According to the cantonal ethical committee, no full ethical approval was needed for this study.

Statistical analysis

The mean values and standard deviations of baseline characteristics were calculated. The Chi-square-test was used to compare categorical data and the Wilcoxon rank-sum (Mann–Whitney) test for non-parametric values. We used a mixed effects logistic regression model to derive odd ratios of prescription of antibiotics and adjusted for patient’s age, number of days of cough, haemoglobin level, WBC (white blood cell) count, and CRP measurements. GP’s age and ability to self-dispense antibiotics were also adjusted for. We selected these co-variables, because they were the most statistically significant differences between patients treated with antibiotics and without as seen in Table 1. Mixed effects logistic regression was used to account for multiple assessments within patient groups, and for clustering of patients depending on treating GPs. Lastly, using STATA release 13.1 (Stata Corp, College Station, TX, USA), we calculated a predictive model with the margins command to estimate the adjusted prediction of all statistically significant co-variables for the prescription of antibiotics. A p-value of 0.05 was considered to be statistically significant.
Table 1
Patient characteristics
Characteristicsa
Overallb(n = 315)
Antibiotic treatment (n = 69)
No antibiotic treatment (n = 241)
p-value
Patients
    
Age, years (SD)
51.1 (18.2)
56.2 (19.0)
49.7 (17.8)
0.02
Women, n (%)
180 (57.1)
37 (53.6)
141 (58.0)
0.47
Smoker, n (%), n = 309
85 (27.5)
19 (27.9)
65 (27.3)
0.92
Nationality, n (%), n = 314
   
0.79
Switzerland
258 (82.2)
57 (82.6)
198 (82.5)
 
Europe
43 (13.7)
10 (14.9)
31 (12.9)
 
Other
13 (4.1)
2 (2.9)
11 (4.6)
 
Demand for antibioticsc, n (%), n = 141
11 (3.4)
11 (15.9)
0 (0)
<0.001
Symptoms
    
Days of cough, n (SD), n = 311
6.7 (4.5)
7.9 (4.9)
6.4 (4.4)
0.02
Sputum, n (%),
167 (53.0)
42 (60.9)
124 (51.5)
0.17
Rhinitis, n (%)
169 (53.7)
30 (43.5)
138 (57.3)
0.04
Sore throat, n (%)
103 (32.7)
18 (26.1)
84 (34.9)
0.17
Fever, n (%)
115 (36.5)
31 (44.9)
84 (34.9)
0.13
Comorbidities, n (%)
   
0.09
Cardiovascular
57 (18.1)
18 (26.1)
39 (16.2)
 
Metabolic
12 (3.8)
4 (5.8)
7 (2.9)
 
Other
33 (10.5)
9 (13.0)
24 (10.0)
 
None
213 (67.6)
38 (55.1)
171 (71.0)
 
Findings
    
Lung auscultation, n (%), n = 314
   
0.001
Rhonchi
36 (11.5)
16 (23.2)
19 (7.9)
 
Wheezing
29 (9.2)
10 (14.5)
19 (7.9)
 
Other
29 (9.2)
6 (8.7)
22 (9.2)
 
Normal auscultation
220 (70.1)
36 (53.7)
181 (74.8)
 
Laboratory done, n (%)
219 (69.5)
56 (81.1)
162 (67.2)
0.03
Haemoglobin, g/l (SD)
141.0 (14.1)
136.3 (13.0)
143.0 (13.9)
0.003
White blood cells, G/l (SD)
7.3 (2.6)
8.7 (3.0)
6.9 (2.3)
<0.001
CRP, mg/dl (SD)
25.0 (38.8)
61.2 (60.5)
12.5 (12.3)
<0.001
Chest X-ray done, n (%)
36 (11.6)
22 (21.9)
14 (5.8)
<0.001
Infiltrate visible, n (%)
12 (33.3)
12 (54.6)
0 (0)
0.001
aFor each characteristic with missing data, a label of “n” is provided behind each characteristic (e.g. Women, n).
bFive patients had missing data concerning antibiotic prescription.
cPatient opposed not to be prescribed antibiotics during consultation.

Results

Baseline characteristics

Medical students registered 348 (3.2%) cases with acute cough out of 10’886 patients that they saw during their attachments. We excluded 33 patients (9%) for various reasons (Flowchart Figure 1). A fifth of patients (22%) were prescribed antibiotics; 78% were treated symptomatically.
Table 1 depicts the baseline characteristics of patients with acute cough. The two groups (with and without antibiotics) differed significantly with regard to age of patient, demand for antibiotics, days of cough, rhinitis, lung auscultation, haemoglobin level, WBC count, CRP measurement, and GPs’ self-dispensation of antibiotics. Table 2 shows characteristics of GPs and their offices.
Table 2
Characteristics of GPs and their offices
General Practitionersa(n = 39)
 
Age, years, n (SD), n = 37
56.4 (6.8)
Experienceb, n, years (SD), n = 38
20.7 (8.2)
Women, n (%), n = 37
6 (16.0)
Self-dispensingc, n (%), n = 37
30 (81.1)
Office location, n (%), n = 37
 
City
11 (29.7)
Suburbs
5 (13.5)
Rural
21 (56.8)
aFor each characteristic with missing data, a label of “n” is provided behind each characteristic (e.g. Women, n).
bNumber of years working as a general practitioner.
cAbility to deliver and sell drugs directly at the GP office.

Prediction of prescription of antibiotics

After logistic regression, only the duration of cough (OR 1.13, 95% CI 1.02-1.27), WBC count (OR 1.33, 95% CI 1.06-1.68) and CRP (OR 1.07, 95% CI 1.03-1.10) emerged as significant predictors for the prescription of antibiotics. Figure 2 shows a predictive model to estimate adjusted prediction for the prescription of antibiotics. Threshold mean values for the prescription of antibiotics are 17 days of cough, leukocyte count of 11 G/l and CRP value of 50 mg/l.

Discussion

In this study, 39 medical students collected data from over 300 patients with acute cough during their three-week clerkships in general practice. A fifth of all patients were prescribed antibiotics. The baseline characteristics of the patients who were or were not prescribed antibiotics differed significantly with regard to age of the patient, the demand of the patient for antibiotics, the duration of cough, rhinitis, lung auscultation, haemoglobin content, white blood cell count, CRP measurement, dispensing of antibiotics by the GPs themselves, and the medical student’ presence during consultation. After regression analysis, however, only three variables remained as firm predictors for the prescription of antibiotics – the duration of cough, WBC count and CRP level.
Blood testing was not performed on all the patients, perhaps due to the effect of the severity of illness on physicians’ decisions to use laboratory tests. Patients who were prescribed antibiotics and had CRP levels checked had a significantly higher CRP than those who were treated symptomatically. Point of care testing for CRP has been shown to be a useful adjunct to clinical decision making in primary care [19]. CRP tests are widely available in Swiss GP practices. They have proven to be of great assistance in deciding whether antibiotics for acute respiratory infections are indicated or not [20]. The usefulness of CRP testing in acute cough and respiratory tract infection for reducing antibiotic prescription has been assessed repeatedly. There is general agreement about the influence of point-of-care CRP results on whether or not to prescribe antibiotics in these situations [21-23]. The views about the diagnostic value of CRP in infections of the lower respiratory tract are, however, controversial [24-26]. André et al. questioned the use of CRP in patients with respiratory tract infections [27]. For patients assigned viral diagnoses, antibiotic prescription increases with increasing duration of symptoms and increasing value of CRP, but in 59% of the patients assigned viral diagnoses, CRP values were not interpreted correctly resulting in a non-optimal use of antibiotics.
A raised leukocyte count has been found to be a non-specific, unreliable indicator of respiratory infection [28]. In this study, however, WBC counts proved to be a reliable predictor for the prescription of antibiotics. This may be due to the fact that automated lab-machines often measure CRP and WBC levels together even though GPs focus on CRP. In our study, 61% of all patients had both laboratory tests. However, CRP was measured in 69% of the cases and WBC counts in 62%. Similarly, GPs are tempted to prescribe antibiotics with the increasing duration of cough although it has been shown that the median duration of untreated cough is up to 18 days [29]. The mismatch between patients’ expectations and the reality of the natural history of acute cough may have important implications for antibiotic prescription. Moreover there is little evidence that antibiotics change the number of days with cough in patients with non-complicated acute bronchitis and discoloured sputum [30-32].
Some Swiss practices have a license to dispense pharmaceuticals, including antibiotics, thus linking diagnostic and therapeutic procedures. This is convenient for patients as they do not need to pay separate visits to pharmacies. The reverse side is that practitioners with dispensaries have financial incentives to prescribe medication. Nevertheless, the availability of laboratory, X-ray, and other diagnostic and therapeutic facilities within practices may be partially responsible for the fact that Switzerland is one of the leaders regarding the restricted use of antibiotics and the country’s high ranking on the Euro Health Consumer Index, with regard to the interval between diagnosis and treatment for a great number of health care aspects [33]. For example, looking at chest X-rays on Table 1, it can be seen that GPs’ feeling the need for such X-rays in order to make a therapeutic decision (antibiotics yes/no) is significantly linked with the prescription of antibiotics, especially when infiltrate visible. The same applies to abnormal sounds from lung auscultation. It can be surmised that acute cough in these patients was seen as the expression of lower respiratory tract infection, e.g. pneumonia.
This cross-sectional study conducted by motivated students and GPs has produced findings which can be considered representative of the national picture, as the equipment of GP practices in Switzerland is quite uniform with regard to the availability of point-of-care laboratory tests, including CRP and blood count, X-ray, lung function tests and electrocardiogram monitors. It enables GPs to reach an accurate diagnosis within a few minutes and to tailor therapeutic medications, especially antibiotics. This is important in view of the ever increasing resistance to antibiotics in Europe [34].

Strengths and weaknesses

This is the first study about predictors of antibiotic prescribing in adult primary care patients with medical students collecting clinical and haematological data during clerkships. Consultations conducted in the presence of students may be considered unrepresentative as GPs might be concerned to set a good example. This is rather unlikely as students were present during the consultation in 86% of all cases but there was no correlation between student presence and GPs’ prescription of antibiotics (p = 0.96). However, the number of patients included was relatively small, and the data quality suffered from some missing data in the data entry process. This may be due to the fact that laboratory investigations were not undertaken in more than around 60% of all patients. The severity of illness may have influenced this decision. Lastly, we did not check on the adequacy of GPs’ prescription of antibiotics over and above the impact of clinical findings and biomarkers.

Conclusions

Medical students collected data from adult patients presenting with acute cough during their three-week clerkships with GPs. Antibiotics were found not to be prescribed as often as in some other countries. CRP level, WBC count and duration of cough turned out to be the main predictors of antibiotic prescription suggesting that GPs use the results of these tests in making treatment decisions.

Acknowledgements

We thank the fourth-year medical students of the University of Bern for data collection and the GPs for their readiness to participate. We thank Dr. Michael Harris and Dr. Douglas Fleming for their comments and suggestions for improvement of the final manuscript. We also thank Angie Ng for proofreading the final manuscript.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

SS: Involved in statistical analysis and interpretation of the data, drafting the manuscript and given final approval to the version to be published. PF: Involved in conception and design of the study, acquisition of data, revising the manuscript and given final approval to the version to be published. SaS: Involved in conception and design of the study, revising the manuscript and given final approval to the version to be published. UB: Involved in conception and design of the study, drafting and revising the manuscript and given final approval to the version to be published. DM: Involved in conception and design of the study, drafting and revising the manuscript and given final approval to the version to be published.
Literatur
1.
Zurück zum Zitat Westert G, Jabaaij L, Schellevis F. Morbidity, Performance and Quality In Primary Care. Abingdon: Radcliffe Publishing Ltd; 2006. Westert G, Jabaaij L, Schellevis F. Morbidity, Performance and Quality In Primary Care. Abingdon: Radcliffe Publishing Ltd; 2006.
2.
Zurück zum Zitat Fahey T, Stocks N, Thomas T. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ. 1998;316:906–10.CrossRefPubMedPubMedCentral Fahey T, Stocks N, Thomas T. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ. 1998;316:906–10.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Butler CC, Hood K, Verheij T, Little P, Melbye H, Nuttall J, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ. 2009;338:b2242.CrossRefPubMedPubMedCentral Butler CC, Hood K, Verheij T, Little P, Melbye H, Nuttall J, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ. 2009;338:b2242.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2004; 4:CD000245 Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2004; 4:CD000245
5.
Zurück zum Zitat Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2005; 3:CD000247. Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2005; 3:CD000247.
6.
Zurück zum Zitat Pan Y, Henderson J, Britt H. Antibiotic prescribing in Australian general practice: how has it changed from 1990–91 to 2002-03? Respir Med. 2006;100:2004–11.CrossRefPubMed Pan Y, Henderson J, Britt H. Antibiotic prescribing in Australian general practice: how has it changed from 1990–91 to 2002-03? Respir Med. 2006;100:2004–11.CrossRefPubMed
7.
Zurück zum Zitat Ashworth M, Charlton J, Ballard K, Latinovic R, Gulliford M. Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995–2000. Br J Gen Pract. 2005;55:603–8.PubMedPubMedCentral Ashworth M, Charlton J, Ballard K, Latinovic R, Gulliford M. Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995–2000. Br J Gen Pract. 2005;55:603–8.PubMedPubMedCentral
8.
Zurück zum Zitat Chung A, Perera R, Brueggemann AB, Elamin AE, Harnden A, Mayon-White R, et al. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ. 2007;335:429.CrossRefPubMedPubMedCentral Chung A, Perera R, Brueggemann AB, Elamin AE, Harnden A, Mayon-White R, et al. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ. 2007;335:429.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patients’ expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ. 1997;315:1211–4.CrossRefPubMedPubMedCentral Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patients’ expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ. 1997;315:1211–4.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kroening-Roche JC, Soroudi A, Castillo EM, Vilke GM. Antibiotic and bronchodilator prescribing for acute bronchitis in the emergency department. J Emerg Med. 2012;43:221–7.CrossRefPubMed Kroening-Roche JC, Soroudi A, Castillo EM, Vilke GM. Antibiotic and bronchodilator prescribing for acute bronchitis in the emergency department. J Emerg Med. 2012;43:221–7.CrossRefPubMed
11.
Zurück zum Zitat Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. Jama. 1997;278:901–4.CrossRefPubMed Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. Jama. 1997;278:901–4.CrossRefPubMed
12.
Zurück zum Zitat Andre M, Odenholt I, Schwan A, Axelsson I, Eriksson M, Hoffman M, et al. Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests. Scand J Infect Dis. 2002;34:880–6.CrossRefPubMed Andre M, Odenholt I, Schwan A, Axelsson I, Eriksson M, Hoffman M, et al. Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests. Scand J Infect Dis. 2002;34:880–6.CrossRefPubMed
13.
Zurück zum Zitat Dosh SA, Hickner JM, Mainous 3rd AG, Ebell MH. Predictors of antibiotic prescribing for nonspecific upper respiratory infections, acute bronchitis, and acute sinusitis. An UPRNet study. Upper Peninsula Research Network. J Fam Pract. 2000;49:407–14.PubMed Dosh SA, Hickner JM, Mainous 3rd AG, Ebell MH. Predictors of antibiotic prescribing for nonspecific upper respiratory infections, acute bronchitis, and acute sinusitis. An UPRNet study. Upper Peninsula Research Network. J Fam Pract. 2000;49:407–14.PubMed
14.
Zurück zum Zitat van der Horst HE, Berger MY. [Patients expect antibiotics. Or not? A folie a deux]. Ned Tijdschr Geneeskd. 2012;156:A4390.PubMed van der Horst HE, Berger MY. [Patients expect antibiotics. Or not? A folie a deux]. Ned Tijdschr Geneeskd. 2012;156:A4390.PubMed
15.
Zurück zum Zitat Akkerman AE, Kuyvenhoven MM, van der Wouden JC, Verheij TJ. Determinants of antibiotic overprescribing in respiratory tract infections in general practice. J Antimicrob Chemother. 2005;56:930–6.CrossRefPubMed Akkerman AE, Kuyvenhoven MM, van der Wouden JC, Verheij TJ. Determinants of antibiotic overprescribing in respiratory tract infections in general practice. J Antimicrob Chemother. 2005;56:930–6.CrossRefPubMed
16.
Zurück zum Zitat Lam TP, Lam KF. Management of upper respiratory tract infection by family doctors. Int J Clin Pract. 2001;55:358–60.PubMed Lam TP, Lam KF. Management of upper respiratory tract infection by family doctors. Int J Clin Pract. 2001;55:358–60.PubMed
17.
Zurück zum Zitat Cadieux G, Tamblyn R, Dauphinee D, Libman M. Predictors of inappropriate antibiotic prescribing among primary care physicians. Cmaj. 2007;177:877–83.CrossRefPubMedPubMedCentral Cadieux G, Tamblyn R, Dauphinee D, Libman M. Predictors of inappropriate antibiotic prescribing among primary care physicians. Cmaj. 2007;177:877–83.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Huang N, Chou YJ, Chang HJ, Ho M, Morlock L. Antibiotic prescribing by ambulatory care physicians for adults with nasopharyngitis, URIs, and acute bronchitis in Taiwan: a multi-level modeling approach. Fam Pract. 2005;22:160–7.CrossRefPubMed Huang N, Chou YJ, Chang HJ, Ho M, Morlock L. Antibiotic prescribing by ambulatory care physicians for adults with nasopharyngitis, URIs, and acute bronchitis in Taiwan: a multi-level modeling approach. Fam Pract. 2005;22:160–7.CrossRefPubMed
19.
Zurück zum Zitat Hersberger KE, Botomino A, Sarkar R, Tschudi P, Bucher HC, Briel M. Prescribed medications and pharmacy interventions for acute respiratory tract infections in Swiss primary care. J Clin Pharm Ther. 2009;34:387–95.CrossRefPubMed Hersberger KE, Botomino A, Sarkar R, Tschudi P, Bucher HC, Briel M. Prescribed medications and pharmacy interventions for acute respiratory tract infections in Swiss primary care. J Clin Pharm Ther. 2009;34:387–95.CrossRefPubMed
20.
Zurück zum Zitat Briel M, Young J, Tschudi P, Hersberger KE, Hugenschmidt C, Langewitz W, et al. Prevalence and influence of diagnostic tests for acute respiratory tract infections in primary care. Swiss Med Wkly. 2006;136:248–53.PubMed Briel M, Young J, Tschudi P, Hersberger KE, Hugenschmidt C, Langewitz W, et al. Prevalence and influence of diagnostic tests for acute respiratory tract infections in primary care. Swiss Med Wkly. 2006;136:248–53.PubMed
21.
Zurück zum Zitat Cals JW, Schot MJ, de Jong SA, Dinant GJ, Hopstaken RM. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med. 2010;8:124–33.CrossRefPubMedPubMedCentral Cals JW, Schot MJ, de Jong SA, Dinant GJ, Hopstaken RM. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med. 2010;8:124–33.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Jakobsen KA, Melbye H, Kelly MJ, Ceynowa C, Mölstad S, Hood K, et al. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scand J Prim Health Care. 2010;28(4):229–36.CrossRefPubMedPubMedCentral Jakobsen KA, Melbye H, Kelly MJ, Ceynowa C, Mölstad S, Hood K, et al. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scand J Prim Health Care. 2010;28(4):229–36.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Andreeva E, Melbye H. Usefulness of C-reactive protein testing in acute cough/ respiratory tract infection. An open cluster-randomized clinical trial with C-reactive protein testing in the intervention group. BMC Fam Pract. 2014;15:80.CrossRefPubMedPubMedCentral Andreeva E, Melbye H. Usefulness of C-reactive protein testing in acute cough/ respiratory tract infection. An open cluster-randomized clinical trial with C-reactive protein testing in the intervention group. BMC Fam Pract. 2014;15:80.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Van der Meer V, Neven AK, van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ. 2005;331:26.CrossRefPubMedPubMedCentral Van der Meer V, Neven AK, van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ. 2005;331:26.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Engel MF, Paling FP, Hoepelman AI, van der Meer V, Oosterheert JJ. Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. Fam Pract. 2012;29:383–93.CrossRefPubMed Engel MF, Paling FP, Hoepelman AI, van der Meer V, Oosterheert JJ. Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. Fam Pract. 2012;29:383–93.CrossRefPubMed
26.
Zurück zum Zitat Van Vugt SF, Broekhuizen BD, Lammens C, Zuithoff NP, de Jong PA, Coenen S, et al. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough; diagnostic study. BMJ. 2013;346:f2450.CrossRefPubMedPubMedCentral Van Vugt SF, Broekhuizen BD, Lammens C, Zuithoff NP, de Jong PA, Coenen S, et al. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough; diagnostic study. BMJ. 2013;346:f2450.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat André M, Schwan A, Odenholt I, Swedish Study Group on Antibiotic Use. The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned. Scand J Infect Dis. 2004;36:192–7.CrossRefPubMed André M, Schwan A, Odenholt I, Swedish Study Group on Antibiotic Use. The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned. Scand J Infect Dis. 2004;36:192–7.CrossRefPubMed
28.
Zurück zum Zitat Chalmers JD, Hill AT. Investigation of “non-responding” presumed lower respiratory tract infection in primary care. BMJ. 2011;343:843–5.CrossRef Chalmers JD, Hill AT. Investigation of “non-responding” presumed lower respiratory tract infection in primary care. BMJ. 2011;343:843–5.CrossRef
29.
Zurück zum Zitat Ebell MH, Lundgren J, Youngpairoj S. How long does a cough last? Comparing patients’expectations with data from a systematic review of the literature. Ann Fam Med. 2013;11:5–13.CrossRefPubMedPubMedCentral Ebell MH, Lundgren J, Youngpairoj S. How long does a cough last? Comparing patients’expectations with data from a systematic review of the literature. Ann Fam Med. 2013;11:5–13.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Moore M, Stuart B, Coenen S, Butler CC, Goossens H, Verheij TJ, et al. Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups. Br J Gen Pract. 2014;64(619):e75–80.CrossRefPubMedPubMedCentral Moore M, Stuart B, Coenen S, Butler CC, Goossens H, Verheij TJ, et al. Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups. Br J Gen Pract. 2014;64(619):e75–80.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Llor C, Moragas A, Bayona C, Morros R, Pera H, Plana-Ripoli O, et al. Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial. BMJ. 2013;347:f5762.CrossRefPubMedPubMedCentral Llor C, Moragas A, Bayona C, Morros R, Pera H, Plana-Ripoli O, et al. Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial. BMJ. 2013;347:f5762.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Butler CC, Kelly MJ, Hood K, Schaberg T, Melbye H, Serra-Prat M, et al. Antibiotic prescribing for discoloured sputum in acute cough/ lower respiratory tract infection. Eur Respir J. 2011;38:119–25.CrossRefPubMed Butler CC, Kelly MJ, Hood K, Schaberg T, Melbye H, Serra-Prat M, et al. Antibiotic prescribing for discoloured sputum in acute cough/ lower respiratory tract infection. Eur Respir J. 2011;38:119–25.CrossRefPubMed
34.
Zurück zum Zitat Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579–87.CrossRefPubMed Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579–87.CrossRefPubMed
Metadaten
Titel
Clinical and haematological predictors of antibiotic prescribing for acute cough in adults in Swiss practices – an observational study
verfasst von
Sven Streit
Peter Frey
Sarah Singer
Ueli Bollag
Damian N Meli
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
BMC Primary Care / Ausgabe 1/2015
Elektronische ISSN: 2731-4553
DOI
https://doi.org/10.1186/s12875-015-0226-9

Weitere Artikel der Ausgabe 1/2015

BMC Family Practice 1/2015 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 49 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Diabetestechnologie für alle?

15.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Eine verbesserte Stoffwechseleinstellung und höhere Lebensqualität – Diabetestechnologien sollen den Alltag der Patienten erleichtern. Dass CGM, AID & Co. bei Typ-1-Diabetes helfen, ist belegt. Bei Typ-2 gestaltet sich die Sache komplizierter.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.